| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8446928 | European Journal of Cancer | 2011 | 5 Pages |
Abstract
RECIST evaluation of tumour response depends on the natural history of the tumours and poorly measures the impact of treatment on the kinetics of tumour growth. Integrating pre-treatment GR evaluations could substantially improve the assessment of treatment efficacy in drug development.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Carlos Gomez-Roca, Serge Koscielny, Vincent Ribrag, Clarisse Dromain, Inès Marzouk, François Bidault, Ratislav Bahleda, Charles Ferté, Christophe Massard, Jean-Charles Soria,